Tariff turnarounds miring Kiwi companies in uncertainty
It's been a busy end to the results season, with the last couple of days particularly flat out with NZX-listed companies with March year-ends releasing their earnings.
Of note included Ryman Healthcare, which sunk deeper into the red on the back of one-off losses, but posted an improved underlying
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
National Business Review
a day ago
- National Business Review
Vital enlists Cameron Partners, Harmos Horton Lusk on takeover
NZX-listed telco infrastructure company Vital has appointed advisers ahead of a possible formal takeover offer from Christchurch-based Tait International. Last month, Tait said it intended to make a full takeover offer for Vital at 45 cents a share. That offer would be payable in cash and subject to
National Business Review
a day ago
- National Business Review
Serko upgraded to ‘outperform' by Forsyth Barr
Forsyth Barr has upgraded its rating of ASX and NZX-listed travel software business Serko based on a belief the company can restore confidence in its revenue growth trajectory by meeting the midpoint of its FY26 income guidance. Analysts James Lindsay and Will Twiss wrote in a research note issued
National Business Review
2 days ago
- National Business Review
Pellet plant developer gets more time from OIO
Energy 2 mins to read Pellet plant developer gets more time from OIO ASX-listed Foresta now has until July 2026 to acquire a lease on the Kawerau site. Foresta wants to build a wood pellet plant on a 9.5ha site at Kawerau.
